Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

NCT06536517 · Johns Hopkins University · Updated 12 Jan 2026

What is being tested
Methadone
For
Fibroid Uterus
Kind of study
Tests a treatment or device on volunteers. Phase 2.
Who can join
Ages 18 years and older. About 100 people. The full rules are on the registry page.
Where
United States (2 sites)
When
Starts or started 7 March 2025, ends Dec 2026. Registered 5 Aug 2024.
Results
None posted yet.

In the researchers' words

Currently, there is a nationwide epidemic of opioid abuse and overdose deaths. One source of excess opioids is overprescribing in the postoperative period. This study aims to find the optimal pain medication plan during and after laparoscopic hysterectomy to eliminate long-term opioid use. Given the increasing opioid abuse and over-prescription post-operatively, an effort should be made to determine whether one time dosing of Methadone, a longer opioid analgesics, intra-operatively is an adequate potential in treating postoperative pain after hysterectomy surgeries. The investigators hypothesize that this could minimize the need for additional post-operative and outpatient opioid prescriptions and decrease the adverse effects that are associated with the consumption, including new opioid abuse. Intervention group will receive methadone intraoperatively while the other group would receive short-acting opioids (standard).
ClinicalTrials.gov, NCT06536517

Sites

  • The Johns Hopkins Bayview Medical CenterBaltimore, Maryland, United States
  • The Johns Hopkins HospitalBaltimore, Maryland, United States